Clinical Executive Summary
Dr. Peter Attia’s Medicine 3.0 framework shifts the clinical objective from reactive late-stage disease treatment to proactive, personalized healthspan extension decades before clinical symptoms emerge. Medicine 3.0 focuses on preventing the Four Horsemen of Chronic Disease: Atherosclerotic Cardiovascular Disease (ASCVD), Cancer, Neurodegenerative Disease (Alzheimer’s), and Metabolic Dysfunction (Type 2 Diabetes / MASLD). By tracking a specialized biomarker stack centered on ApoB, Lp(a), Fasting Insulin, OGTT, hs-CRP, Uric Acid, and Cystatin C, patients can deploy targeted exercise (Zone 2, VO2 max), nutritional, and pharmacological levers to delay chronic pathology indefinitely.
In his landmark work Outlive: The Science and Art of Longevity, Dr. Peter Attia articulated a profound distinction that is reshaping modern clinical medicine:
The distinction between Medicine 2.0 and Medicine 3.0.
Medicine 2.0 is the conventional healthcare model we all grew up with: it treats you when you are already sick. It waits until a coronary artery is 90% occluded to insert a stent; waits until fasting glucose hits 126 mg/dL to prescribe metformin; and waits until a patient experiences memory loss to diagnose cognitive impairment.
Medicine 3.0 completely upends this timeline:
It operates on the premise that the chronic diseases that kill 80% of adults: the "Four Horsemen": have incubation periods lasting twenty, thirty, or even forty years.
By measuring the exact biological drivers of cellular damage in your thirties, forties, and fifties, you can intervene when diseases are completely reversible.
What comprises the definitive Peter Attia-inspired longevity lab panel, how often should each marker be tested, and what are the evidence-based clinical playbooks when your numbers drift?
1. The Medicine 2.0 vs. Medicine 3.0 Diagnostic Spectrum#
[THE EVOLUTION OF MEDICAL DIAGNOSTICS]
MEDICINE 2.0 (The Reactive Trap):
- Primary Metric: Total Cholesterol & LDL-C.
- Glycemic Metric: Fasting Glucose (ignores Fasting Insulin!).
- Intervention Threshold: When you cross into official pathology (e.g., A1c >= 6.5%).
- Strategy: "Let's wait and see how you look next year."
VS.
MEDICINE 3.0 (The Proactive Longevity Architecture):
- Primary Metric: Apolipoprotein B (ApoB) & Lipoprotein(a).
- Glycemic Metric: Fasting Insulin, Oral Glucose Tolerance Test (OGTT), Continuous Glucose (CGM).
- Intervention Threshold: When biomarkers drift from OPTIMAL (e.g., Fasting Insulin > 5.0 µIU/mL).
- Strategy: "Aggressive early lifestyle and pharmacological optimization today."
2. The Attia Longevity Biomarker Stack#
Dr. Attia’s diagnostic framework targets the specific pathological drivers of each of the Four Horsemen:
[THE ATTIA LONGEVITY BIOMARKER STACK]
│
┌───────────────────┬─────────────┼─────────────┬───────────────────┐
▼ ▼ ▼ ▼ ▼
[1. CARDIOVASCULAR] [2. METABOLIC] [3. INFLAMMATORY] [4. RENAL / HEPATIC] [5. ANABOLIC / BONE]
- ApoB (< 60 mg/dL). - Fasting Insulin. - hs-CRP (< 0.5). - Cystatin C eGFR. - DEXA T-Scores.
- Lp(a) (Once). - OGTT (2-Hour). - Homocysteine. - ALT (< 20 U/L). - Free Testosterone.
- CAC Scan / CCTA. - Uric Acid. - Fibrinogen. - GGT (< 20 U/L). - 25(OH)D (> 40).
1. Atherosclerosis & Vascular Plaque Prevention#
- Apolipoprotein B (ApoB): Measures the total atherogenic particle count. Longevity Target: < 60 to 70 mg/dL (Primary) / < 50 mg/dL (High Risk).
- Lipoprotein(a) [Lp(a)]: Genetically fixed risk factor for premature coronary disease and aortic stenosis. Test once. Target: < 30 mg/dL (< 75 nmol/L).
- Anatomical Plaque Imaging: Baseline Coronary Artery Calcium (CAC) scan at age 40 to 50, or an AI-guided Coronary Computed Tomography Angiography (CCTA) to detect soft, non-calcified plaque.
2. Metabolic Dysfunction & Insulin Sensitivity#
- Fasting Insulin: Identifies compensatory hyperinsulinemia 10+ years before fasting glucose elevates. Target: < 5.0 µIU/mL.
- Oral Glucose Tolerance Test (OGTT) with Insulin Kraft Curve: 75g glucose challenge measuring insulin response at 30, 60, and 120 minutes.
- Serum Uric Acid: Sensitive proxy for hepatic fructose overload and endothelial nitric oxide inhibition. Target: < 5.0 mg/dL.
3. Chronic Systemic Inflammation#
- High-Sensitivity CRP (hs-CRP): Direct vascular inflammation marker. Target: < 0.5 mg/L.
- Homocysteine: Endothelial toxin and methylation marker. Target: 6.0 to 8.5 µmol/L.
4. Organ Quietude & Clearance#
- Cystatin C-based eGFR: Glomerular filtration measurement independent of muscle mass or creatine intake. Target: > 90 to 100 mL/min/1.73m².
- Alanine Aminotransferase (ALT): Target: < 20 to 25 U/L.
- Gamma-Glutamyl Transferase (GGT): Target: < 20 U/L.
3. Recommended Testing Frequency Cadence#
| Diagnostic Test | Cadence | Purpose |
|---|---|---|
| ApoB, Fasting Insulin, hs-CRP, CMP, CBC | Every 3 to 6 Months | Core metabolic and cardiovascular tracking; rapid iteration of diet and exercise. |
| Complete Micronutrients (Vitamin D, Ferritin, Homocysteine) | Every 6 Months | Monitoring supplement dosing and cellular stores. |
| Lipoprotein(a) | Once in a Lifetime | 80–90% genetically determined; establishes lifelong vascular baseline. |
| Coronary Calcium (CAC) Scan | Every 3 to 5 Years | Anatomical confirmation of zero calcified coronary plaque. |
| DEXA Bone & Body Composition | Every 12 Months | Quantifies lean visceral fat mass and femoral neck bone mineral density (T-Score). |
4. What To Do When the Data Drifts (The Action Playbook)#
THE ATTIA INTERVENTION PLAYBOOK:
1. If ApoB is Elevated (> 80 mg/dL):
- Nutritional Lever: Restrict saturated fatty acids (butter, heavy cream, fatty beef);
increase dietary viscous soluble fiber (psyllium husk, legumes).
- Pharmacological Lever: If lifestyle fails to reach < 60 mg/dL, discuss low-dose statins
(Rosuvastatin/Pitavastatin) + Ezetimibe or PCSK9 inhibitors.
2. If Fasting Insulin is Elevated (> 6.0 µIU/mL):
- Exercise Lever: Increase Zone 2 low-intensity endurance training to 3 to 4 hours per week
to expand mitochondrial oxidative capacity and GLUT4 glucose disposal.
- Nutritional Lever: Eliminate liquid carbohydrates and refined starches; consider 16:8
time-restricted feeding.
3. If hs-CRP is Elevated (> 1.0 mg/L):
- Protocol: Rule out dental infections, optimize sleep duration (> 7.5 hours), eliminate
ultra-processed seed oils, and add high-potency EPA/DHA Omega-3s (2 to 4g daily).
5. Summary Clinical Recommendations#
- Adopt the Medicine 3.0 Mindset: Treat your health as an investment portfolio that requires proactive risk mitigation decades before retirement.
- Prioritize ApoB, Fasting Insulin, and hs-CRP: These three analytes represent the foundational triangle of healthspan optimization.
- Track Trends Systematically: Never look at a lab report as an isolated static event; monitor the multi-year velocity of change.
Blood biomarkers must be paired with physical fitness metrics. Dr. Attia highlights that having a high VO2 max (top decile for age) and high muscle mass confers greater all-cause mortality reduction than any pharmacological drug known to modern medicine.
To learn how to track biological age using standard blood biomarkers, read How To Track Your Biological Age Using Standard Blood Biomarkers.
Scientific References & Primary Literature#
- Attia P, Gifford B. Outlive: The Science and Art of Longevity. New York: Harmony Books; 2023.
- Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295. doi:10.1001/jamacardio.2019.3780.
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER Trial). N Engl J Med. 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646.
- Mandsager K, Harb S, Cremer P, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605. doi:10.1001/jamanetworkopen.2018.3605.
- Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953.
Track Your Medicine 3.0 Biomarkers with Meridian#
Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your metabolic health and glucose tolerance in optimal ranges.
Meridian: My Lab Records Home is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.
- 100% On-Device & Zero-Knowledge: Protected by hardware AES-256 keychain encryption and FaceID. Zero cloud servers. Zero data tracking.
- Autonomous Local OCR with Guided ROI: Ingests paper lab reports and multi-page PDFs locally using Apple Vision with interactive table cropping for 100% data accuracy.
- Longitudinal Velocity Tracking & Organ Mapping: Track your personal biological baselines, calculate rate-of-change ((Δ/month)), and manage multi-profile family health records in one offline vault.
Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.